Cagrilintide is a long-acting amylin analog studied for appetite and weight, often with semaglutide. It is researched most often for Appetite regulation, Weight management and Satiety. Clinical trials — investigational. This guide walks through what Cagrilintide is, how it's studied, what it's commonly combined with, and — just as important — where the science stops. It's educational information only, not medical advice.
What is Cagrilintide?
Cagrilintide is a long-acting amylin analog that influences appetite and satiety. It has been studied both on its own and in combination with semaglutide (as CagriSema) for weight management.
Also known as: Cagri, AM833.
How does Cagrilintide work?
Cagrilintide is a long-acting analog of amylin, a hormone co-released with insulin that promotes satiety and slows gastric emptying. It is studied on its own and combined with semaglutide (as CagriSema) for appetite and weight management.
What is Cagrilintide researched for?
In the research and community discussion, Cagrilintide comes up most often in connection with Appetite regulation, Weight management and Satiety. Remember that "researched for" is not the same as "proven to treat" — these are the directions the science has explored, not established outcomes.
- Appetite regulation
- Weight management
- Satiety
What does the research actually show?
Clinical trials — investigational. The honest framing matters here: promising mechanisms and early results are genuinely interesting, but they are not the same as proven, approved therapy. Anyone presenting Cagrilintide as a guaranteed treatment is getting ahead of the evidence.
What is Cagrilintide typically stacked with?
In the literature and community discussion, Cagrilintide is most often combined with Semaglutide, based on complementary mechanisms. Selpho never provides dosing or protocols — combinations should only be considered with a licensed professional, since interactions and individual context matter.
Safety and considerations
Investigational and not approved as a standalone product. Medical supervision advised. Because the responsible framing is educational rather than prescriptive, Selpho provides no dosing, protocols, or purchase links, and always points back to a licensed professional for any decision. If you are dealing with a real health concern, that professional — not a peptide — is where planning should start.
Where to learn more about Cagrilintide
To go deeper, see the Cagrilintide library page for a quick reference; published research on PubMed; Selpho's free AI Peptide Advisor to see where Cagrilintide might fit your goals.
Frequently asked questions
Appetite regulation and weight management, both alone and in combination with semaglutide. It is investigational.
Amylin is a hormone released with insulin that promotes fullness; a long-acting analog like cagrilintide extends that satiety effect.
No. It is investigational and studied in clinical trials, not approved as a standalone product.
Not sure if Cagrilintide fits your goals?
Describe your situation and Selpho's free AI advisor will suggest research-backed peptides — no signup needed.
Try the Peptide AdvisorThis guide is for educational purposes only and is not medical advice, a diagnosis, or a recommendation to use any compound. It contains no dosing or purchase information. Always consult a licensed healthcare professional before considering any peptide.